Research Impact: How different doses of MVPA may protect against depression remains understudied, particularly among the chronically-ill. Using 10 years of data from The Irish Longitudinal Study on Ageing, we quantified longitudinal associations between MVPA doses and depressive symptoms and Major Depression among 2,262 older adults living with type 2 diabetes. Those adhering to the WHO guidelines of 600-<1,200 MET.min.week−1 had 28% lower odds of Major Depression compared to those not achieving the guidelines (OR: 0.72; 95%CI: 0.53–0.98). For depressive symptoms, a 13% (IRR: 0.87; 95%CI: 0.82–0.93) lower rate of symptoms was found among those exceeding recommendations (1200-<2,400 MET.min.week−1).
Laird E, Herring MP, Carson BP, Woods CB, Walsh C, Kenny RA, Rasmussen CL (2023). Physical activity for depression among the chronically ill: Results from older diabetics in The Irish Longitudinal Study on Ageing. Psychiatry Research, 326:115274. (IF: 11.225; C=; Q1 Psychiatry; R=16/155) DOI: 10.1016/j.psychres.2023.115274
PESS News & Information 